Matsuoka Hiromichi, Yoshiuchi Kazuhiro, Koyama Atsuko, Makimura Chihiro, Fujita Yoshihiko, Tsurutani Junji, Sakai Kiyohiro, Sakamoto Ryo, Nishio Kazuto, Nakagawa Kazuhiko
Department of Psychosomatic Medicine, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Department of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Int J Behav Med. 2017 Aug;24(4):535-541. doi: 10.1007/s12529-017-9644-5.
Cancer pain is a multidimensional experience that includes physiological, sensory, affective, cognitive, behavioral, and sociocultural dimensions. Few prospective studies have examined the relationship between a patient's expectation of pain improvement and the pain prognosis. The aim of this prospective study was to investigate whether patients' expectation to pain reduction was associated with pain intensity after morphine treatment in opioid treatment-naïve patients with various types of cancer.
The subjects were patients scheduled for cancer pain treatment with morphine who were taking nonsteroidal anti-inflammatory drugs daily. Morphine treatment was performed according to the standard method, including titration (NCCN Guidelines™, Adult Cancer Pain). Simple regression analysis was performed between pain intensity numerical rating scale (NRS) (day 8) as the dependent variable, expectation of pain decrease NRS (day 1), tumor types, and the following covariates as independent variables: patients' characteristics such as age, gender, PS (day 1), genotype of catechol-O-methyltransferase, total scores of Hospital Anxiety and Depression Scale (day 1), and pain intensity NRS (day 1). Multiple regression analysis was performed using forced entry methods with pain intensity NRS (day 8) as the dependent variable, and expectation of pain decrease NRS (day 1) and the covariates as independent variables that had a p value <0.05 in the simple regression models.
A total of 100 patients with baseline data were included, and 97 patients (51% female) met the inclusion criteria. Patients with a high expectation of pain decrease NRS had a significantly lower pain intensity NRS (day 8) (p = 0.001).
Non-pharmacological factors such as expectations for pain treatment could also be important factors to treat cancer pain, which might be associated with communication skills in physicians.
癌症疼痛是一种多维度体验,包括生理、感觉、情感、认知、行为和社会文化维度。很少有前瞻性研究探讨患者对疼痛改善的期望与疼痛预后之间的关系。这项前瞻性研究的目的是调查在初次接受阿片类药物治疗的各类癌症患者中,患者对疼痛减轻的期望是否与吗啡治疗后的疼痛强度相关。
研究对象为计划接受吗啡治疗癌症疼痛且每日服用非甾体抗炎药的患者。吗啡治疗按照标准方法进行,包括滴定(NCCN指南™,成人癌症疼痛)。以疼痛强度数字评定量表(NRS)(第8天)作为因变量,疼痛减轻期望NRS(第1天)、肿瘤类型以及以下协变量作为自变量进行简单回归分析:患者特征,如年龄、性别、PS(第1天)、儿茶酚-O-甲基转移酶基因型、医院焦虑抑郁量表总分(第1天)以及疼痛强度NRS(第1天)。使用强制进入法进行多元回归分析,以疼痛强度NRS(第8天)作为因变量,疼痛减轻期望NRS(第1天)和在简单回归模型中p值<0.05的协变量作为自变量。
共纳入100例有基线数据的患者,97例患者(51%为女性)符合纳入标准。疼痛减轻期望NRS较高的患者疼痛强度NRS(第8天)显著更低(p = 0.001)。
对疼痛治疗的期望等非药物因素也可能是治疗癌症疼痛的重要因素,这可能与医生的沟通技巧有关。